Primary Menu
Skip to content
About Us
Management
Board of Directors
Advisors
Science
What are Bacteriophages?
How Bacteriophage Work
Knowledge Library
Pipeline
AB-SA01
AB-PA01
Expanded Access
News
Investors
Press Releases
Events and Presentations
Stock Information
Analyst Coverage
Corporate Governance
SEC Filings
Annual Report & Proxy
Investor Contacts
Contact
Business Opportunities
Careers
Press Releases
Press Releases
Events and Presentations
Stock Information
Analyst Coverage
Corporate Governance
SEC Filings
Annual Report & Proxy
Investor Contacts
Login
all
2018
2017
2016
2015
2014
2013
Nov 14 2017
AmpliPhi Biosciences Reports Third Quarter 2017 Financial Results and Business Highlights
Nov 08 2017
AmpliPhi Biosciences to Hold 2017 Third Quarter and Business Update Conference Call on November 14
Oct 31 2017
AmpliPhi Biosciences to Participate in the BIO-Europe 2017 Conference
Oct 11 2017
AmpliPhi Biosciences to Participate in Two Upcoming Conferences
Oct 02 2017
AmpliPhi Biosciences Announces Publication of Preclinical Data for AB-PA01 Showing Activity in Reducing Biofilms of Pseudomonas Aeruginosa
Sep 18 2017
AmpliPhi Biosciences’ CEO to Moderate Panel Discussion at Upcoming Anti-Infectives Rx Conference
Sep 11 2017
AmpliPhi Biosciences Announces First Intravenous Treatment of a Patient with AB-SA01 Targeting Staphylococcus aureus
Sep 06 2017
AmpliPhi Biosciences Announces Receipt of $2.0 Million R&D Tax Incentive
Sep 05 2017
AmpliPhi Biosciences to Present at Rodman & Renshaw 19th Annual Global Investment Conference
Aug 21 2017
AmpliPhi Biosciences Announces Publication of Bacteriophage Case Study for Life-Threatening Antibiotic-Resistant Infection
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
About Us
Management
Board of Directors
Advisors
Science
What are Bacteriophage?
How Bacteriophage Work
Knowledge Library
Pipeline
AB-SA01
AB-PA01
Expanded Access
News
Investors
Press Releases
Events and Presentations
Stock Information
Analyst Coverage
Corporate Governance
SEC Filings
Annual Report & Proxy
Investor Contacts
Contact
Careers
Business Opportunities
Business Wire InvestorHQ
sm
